FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update from its ...

Lieberman is leader of the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center ... In most healthy individuals, EBV reactivation is asymptomatic because other ...

This summer’s IPO by Artiva Biotherapeutics Inc. highlighted early stage efforts with natural killer cells in autoimmune disease, where a handful of companies are advancing programs. The firm raised ...

GMP Cell Therapy Consumables market is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.2% from 2024 to 2031.